These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 23018305)

  • 1. The effect of beta-blockade on myocardial remodelling in Chagas' cardiomyopathy.
    Pimentel Wde S; Ramires FJ; Lanni BM; Salemi VM; Bilate AM; Cunha-Neto E; Oliveira AM; Fernandes F; Mady C
    Clinics (Sao Paulo); 2012 Sep; 67(9):1063-9. PubMed ID: 23018305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relation between heart rate, heart rhythm, and reverse left ventricular remodelling in response to carvedilol in patients with chronic heart failure: a single centre, observational study.
    Arnold RH; Kotlyar E; Hayward C; Keogh AM; Macdonald PS
    Heart; 2003 Mar; 89(3):293-8. PubMed ID: 12591834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of carvedilol in comparison with metoprolol on myocardial collagen postinfarction.
    Wei S; Chow LT; Sanderson JE
    J Am Coll Cardiol; 2000 Jul; 36(1):276-81. PubMed ID: 10898446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aldosterone antagonism in an inflammatory state: evidence for myocardial protection.
    Ramires FJ; Salemi VM; Ianni BM; Fernandes F; Martins DG; Billate A; Neto EC; Mady C
    J Renin Angiotensin Aldosterone Syst; 2006 Sep; 7(3):162-7. PubMed ID: 17094053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized trial of carvedilol after renin-angiotensin system inhibition in chronic Chagas cardiomyopathy.
    Botoni FA; Poole-Wilson PA; Ribeiro AL; Okonko DO; Oliveira BM; Pinto AS; Teixeira MM; Teixeira AL; Reis AM; Dantas JB; Ferreira CS; Tavares WC; Rocha MO
    Am Heart J; 2007 Apr; 153(4):544.e1-8. PubMed ID: 17383291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological interventions for treating heart failure in patients with Chagas cardiomyopathy.
    Martí-Carvajal AJ; Kwong JS
    Cochrane Database Syst Rev; 2016 Jul; 7(7):CD009077. PubMed ID: 27388039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autonomic dysfunction and beta blocker therapy in Chagas heart disease.
    Bestetti RB; Cardinalli-Neto A
    Clinics (Sao Paulo); 2013; 68(2):275-6. PubMed ID: 23525327
    [No Abstract]   [Full Text] [Related]  

  • 8. Carvedilol may alleviate late cardiac remodelling following surgical ventricular restoration.
    Yoshikawa E; Marui A; Tsukashita M; Nishina T; Wang J; Muranaka H; Ikeda T; Komeda M
    Eur J Cardiothorac Surg; 2010 Feb; 37(2):362-7. PubMed ID: 19692266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of carvedilol treatment on chronic heart failure in pediatric patients with dilated cardiomyopathy: a prospective, randomized-controlled study.
    Huang M; Zhang X; Chen S; Sun Y; Xiao Y; Sun J; Huang M; Chen S; Liu F
    Pediatr Cardiol; 2013 Mar; 34(3):680-5. PubMed ID: 23108482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of carvedilol on diastolic function in patients with diastolic heart failure and preserved systolic function. Results of the Swedish Doppler-echocardiographic study (SWEDIC).
    Bergström A; Andersson B; Edner M; Nylander E; Persson H; Dahlström U
    Eur J Heart Fail; 2004 Jun; 6(4):453-61. PubMed ID: 15182771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Syrian hamster as a model for the dilated cardiomyopathy of Chagas' disease: a quantitative echocardiographical and histopathological analysis.
    Bilate AM; Salemi VM; Ramires FJ; de Brito T; Silva AM; Umezawa ES; Mady C; Kalil J; Cunha-Neto E
    Microbes Infect; 2003 Oct; 5(12):1116-24. PubMed ID: 14554253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carvedilol prevents myocardial fibrosis in hamsters.
    Nanjo S; Yamazaki J; Yoshikawa K; Ishii T; Togane Y
    Int Heart J; 2006 Jul; 47(4):607-16. PubMed ID: 16960415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Carvedilol on Serum Heart-type Fatty Acid-binding Protein, Brain Natriuretic Peptide, and Cardiac Function in Patients With Chronic Heart Failure.
    Sun YP; Wei CP; Ma SC; Zhang YF; Qiao LY; Li DH; Shan RB
    J Cardiovasc Pharmacol; 2015 May; 65(5):480-4. PubMed ID: 25945865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological interventions for treating heart failure in patients with chagas cardiomyopathy.
    Hidalgo R; Martí-Carvajal AJ; Kwong JS; Simancas-Racines D; Nicola S
    Cochrane Database Syst Rev; 2012 Nov; 11():CD009077. PubMed ID: 23152267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carvedilol prevents severe hypertensive cardiomyopathy and remodeling.
    Barone FC; Campbell WG; Nelson AH; Feuerstein GZ
    J Hypertens; 1998 Jun; 16(6):871-84. PubMed ID: 9663928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-blockade therapy in chronic heart failure: diastolic function and mitral regurgitation improvement by carvedilol.
    Capomolla S; Febo O; Gnemmi M; Riccardi G; Opasich C; Caporotondi A; Mortara A; Pinna GD; Cobelli F
    Am Heart J; 2000 Apr; 139(4):596-608. PubMed ID: 10740140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effects of carvedilol in idiopathic dilated cardiomyopathy with persistent left ventricular dysfunction despite chronic metoprolol. The Heart-Muscle Disease Study Group.
    Di Lenarda A; Sabbadini G; Salvatore L; Sinagra G; Mestroni L; Pinamonti B; Gregori D; Ciani F; Muzzi A; Klugmann S; Camerini F
    J Am Coll Cardiol; 1999 Jun; 33(7):1926-34. PubMed ID: 10362195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac remodeling in coronary artery disease.
    Sharpe N
    Am J Cardiol; 2004 May; 93(9A):17B-20B. PubMed ID: 15144932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of carvedilol on systolic and diastolic left ventricular performance in idiopathic dilated cardiomyopathy or ischemic cardiomyopathy.
    Quaife RA; Gilbert EM; Christian PE; Datz FL; Mealey PC; Volkman K; Olsen SL; Bristow MR
    Am J Cardiol; 1996 Oct; 78(7):779-84. PubMed ID: 8857482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of B-Blockers on outcome of patients with Chagas' cardiomyopathy with chronic heart failure.
    Bestetti RB; Otaviano AP; Cardinalli-Neto A; da Rocha BF; Theodoropoulos TA; Cordeiro JA
    Int J Cardiol; 2011 Sep; 151(2):205-8. PubMed ID: 20591516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.